Shandong Xinhua Pharmaceutical Co (HKSE:00719) E10: HK$0.22 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00719 Shandong Xinhua Pharmaceutical Co Ltd HKSE:00719
94 GF Score
Price HK$6.03
GF Value HK$8.18
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shandong Xinhua Pharmaceutical Co E10?

Shandong Xinhua Pharmaceutical Co HKSE:00719 -2.74% 94 E10 is HK$0.22 as of Mar. 2026. GuruFocus rates HKSE:00719 with a GF Score™ of 94/100 and a GF Value™ of HK$8.18 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shandong Xinhua Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was HK$0.136. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is HK$0.22 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shandong Xinhua Pharmaceutical Co's average E10 Growth Rate was 6.10% per year. During the past 3 years, the average E10 Growth Rate was 11.30% per year. During the past 5 years, the average E10 Growth Rate was 14.30% per year. During the past 10 years, the average E10 Growth Rate was 17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Shandong Xinhua Pharmaceutical Co was 22.90% per year. The lowest was 0.00% per year. And the median was 16.00% per year.

As of today (2026-07-24), Shandong Xinhua Pharmaceutical Co's current stock price is HK$6.03. Shandong Xinhua Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was HK$0.22. Shandong Xinhua Pharmaceutical Co's Shiller PE Ratio of today is 27.41.

During the past 13 years, the highest Shiller PE Ratio of Shandong Xinhua Pharmaceutical Co was 131.71. The lowest was 22.98. And the median was 36.15.


Shandong Xinhua Pharmaceutical Co  (HKSE:00719) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shandong Xinhua Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=6.03/0.22
=27.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Shandong Xinhua Pharmaceutical Co was 131.71. The lowest was 22.98. And the median was 36.15.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shandong Xinhua Pharmaceutical Co E10 Related Terms


Shandong Xinhua Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Shandong Xinhua Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Xinhua Pharmaceutical Co E10 Chart

Shandong Xinhua Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.10 0.12 0.18 0.22

Shandong Xinhua Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.22 0.24 0.22 0.22

HKSE:00719 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Xinhua Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Xinhua Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Xinhua Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Xinhua Pharmaceutical Co's Shiller PE Ratio falls into.


HKSE:00719
94GF Score
Shandong Xinhua Pharmaceutical Co Ltd HKSE:00719
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Xinhua Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shandong Xinhua Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.136/116.3033*116.3033
=0.136

Current CPI (Mar. 2026) = 116.3033.

Shandong Xinhua Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.054 101.400 0.062
201609 0.081 102.400 0.092
201612 0.060 102.600 0.068
201703 0.095 103.200 0.107
201706 0.106 103.100 0.120
201709 0.131 104.100 0.146
201712 0.071 104.500 0.079
201803 0.137 105.300 0.151
201806 0.109 104.900 0.121
201809 0.126 106.600 0.137
201812 0.114 106.500 0.124
201903 0.140 107.700 0.151
201906 0.136 107.700 0.147
201909 0.165 109.800 0.175
201912 0.100 111.200 0.105
202003 0.155 112.300 0.161
202006 0.153 110.400 0.161
202009 0.137 111.700 0.143
202012 0.142 111.500 0.148
202103 0.191 112.662 0.197
202106 0.193 111.769 0.201
202109 0.157 112.215 0.163
202112 0.122 113.108 0.125
202203 0.210 114.335 0.214
202206 0.152 114.558 0.154
202209 0.157 115.339 0.158
202212 0.190 115.116 0.192
202303 0.251 115.116 0.254
202306 0.186 114.558 0.189
202309 0.193 115.339 0.195
202312 0.164 114.781 0.166
202403 0.228 115.227 0.230
202406 0.183 114.781 0.185
202409 0.121 115.785 0.122
202412 0.192 114.893 0.194
202503 0.161 115.116 0.163
202506 0.186 114.907 0.188
202509 0.055 115.471 0.055
202512 0.055 115.832 0.055
202603 0.136 116.303 0.136

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of HK$0.22 mean?
Shandong Xinhua Pharmaceutical Co (HKSE:00719) has a E10 of HK$0.22 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shandong Xinhua Pharmaceutical Co and its competitors.
Is Shandong Xinhua Pharmaceutical Co's E10 too high?
Shandong Xinhua Pharmaceutical Co's current E10 is HK$0.22. Overall, Shandong Xinhua Pharmaceutical Co has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Xinhua Pharmaceutical Co's E10 compare to ZTS and UTHR?
Shandong Xinhua Pharmaceutical Co's E10 of HK$0.22 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shandong Xinhua Pharmaceutical Co and its competitors. Shandong Xinhua Pharmaceutical Co's current E10 is HK$0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Xinhua Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co (HKSE:00719) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$8.18, compared to a current price of HK$6.03 — trading 26.3% below its estimated fair value. The current E10 is HK$0.22. Shandong Xinhua Pharmaceutical Co's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Shandong Xinhua Pharmaceutical Co (HKSE:00719), the current E10 is HK$0.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Xinhua Pharmaceutical Co (HKSE:00719) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co stock appears to be undervalued. The current stock price of HK$6.03 is trading 26.3% below its estimated GF Value™ of HK$8.18. GuruFocus considers Shandong Xinhua Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for HKSE:00719:

  • E10: HK$0.22
  • GF Value™: HK$8.18 vs. price of HK$6.03 (26.3% below fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the HKSE:00719 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Xinhua Pharmaceutical Co Business Description

Other Exchanges XIN:Germany000756:China
Address No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.
94GF Score

Get the complete analysis for HKSE:00719

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.03
Price
HK$8.18
GF Value